Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

HS-20094

RISE-1

Regeneron · Phase 3 · Not yet recruiting · Enrollment 3000

NCT07896265

ArmPopulationDoseWeeksEstimandWeight change
Olatorepatide-Dose 1Obesity, no T2Dn/rn/rn/rn/r
Olatorepatide-Dose 2Obesity, no T2Dn/rn/rn/rn/r
Olatorepatide-Dose 3Obesity, no T2Dn/rn/rn/rn/r
Placebo-Dose 1Obesity, no T2Dn/rn/rn/rn/r
Placebo-Dose 2Obesity, no T2Dn/rn/rn/rn/r